These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 444100)

  • 1. Early-morning dystonia. A late side effect of long-term levodopa therapy in Parkinson's disease.
    Melamed E
    Arch Neurol; 1979 May; 36(5):308-10. PubMed ID: 444100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early morning dystonia in Parkinson's disease.
    Currie LJ; Harrison MB; Trugman JM; Bennett JP; Wooten GF
    Neurology; 1998 Jul; 51(1):283-5. PubMed ID: 9674823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Off" painful dystonia in Parkinson's disease treated with botulinum toxin.
    Pacchetti C; Albani G; Martignoni E; Godi L; Alfonsi E; Nappi G
    Mov Disord; 1995 May; 10(3):333-6. PubMed ID: 7651452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forms of dystonia in patients with Parkinson's disease.
    Kidron D; Melamed E
    Neurology; 1987 Jun; 37(6):1009-11. PubMed ID: 3587617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. End-of-dose dystonia in Parkinson's disease.
    Bravi D; Mouradian MM; Roberts JW; Davis TL; Chase TN
    Neurology; 1993 Oct; 43(10):2130-1. PubMed ID: 8413978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early morning off-medication dyskinesias, dystonia, and choreic subtypes.
    Cubo E; Gracies JM; Benabou R; Olanow CW; Raman R; Leurgans S; Goetz CG
    Arch Neurol; 2001 Sep; 58(9):1379-82. PubMed ID: 11559308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity.
    Krack P; Pollak P; Limousin P; Benazzouz A; Deuschl G; Benabid AL
    Brain; 1999 Jun; 122 ( Pt 6)():1133-46. PubMed ID: 10356065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.
    Marconi R; Lefebvre-Caparros D; Bonnet AM; Vidailhet M; Dubois B; Agid Y
    Mov Disord; 1994 Jan; 9(1):2-12. PubMed ID: 8139601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spectrum of levodopa-induced dyskinesias.
    Fahn S
    Ann Neurol; 2000 Apr; 47(4 Suppl 1):S2-9; discussion S9-11. PubMed ID: 10762127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dystonia in Parkinson's disease: clinical and pharmacological features.
    Poewe WH; Lees AJ; Stern GM
    Ann Neurol; 1988 Jan; 23(1):73-8. PubMed ID: 3345068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Problems of long-term levodopa therapy in Parkinson's disease].
    Nakamura Y
    Nihon Rinsho; 1997 Jan; 55(1):65-71. PubMed ID: 9014425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiapride in levodopa-induced involuntary movements.
    Lees AJ; Lander CM; Stern GM
    J Neurol Neurosurg Psychiatry; 1979 Apr; 42(4):380-3. PubMed ID: 458486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do parkinsonian symptoms and levodopa-induced dyskinesias start in the foot?
    Vidailhet M; Bonnet AM; Marconi R; Gouider-Khouja N; Agid Y
    Neurology; 1994 Sep; 44(9):1613-6. PubMed ID: 7936284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of treatment with levodopa on Parkinson's disease.
    Shaw KM; Lees AJ; Stern GM
    Q J Med; 1980; 49(195):283-93. PubMed ID: 7465763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dystonia in untreated parkinsonism.
    LeWitt PA; Burns RS; Newman RP
    Clin Neuropharmacol; 1986; 9(3):293-7. PubMed ID: 3719574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.
    Zimmerman TR; Sage JI; Lang AE; Mark MH
    Mov Disord; 1994 Mar; 9(2):173-7. PubMed ID: 8196678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex dystonia of Parkinson's disease: clinical features and relation to plasma levodopa profile.
    McHale DM; Sage JI; Sonsalla PK; Vitagliano D
    Clin Neuropharmacol; 1990 Apr; 13(2):164-70. PubMed ID: 2328507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced motor complications in dopa-responsive dystonia: implications for the pathogenesis of dyskinesias and motor fluctuations.
    de la Fuente-Fernández R
    Clin Neuropharmacol; 1999; 22(4):216-9. PubMed ID: 10442251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical characteristics of painful dystonic foot response in patients with Parkinson's disease].
    Hara H; Wakayama Y; Kawase J
    Rinsho Shinkeigaku; 1989 Sep; 29(9):1101-5. PubMed ID: 2598534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Madopar HBS in nocturnal symptoms of Parkinson's disease.
    Jansen EN; Meerwaldtt JD
    Adv Neurol; 1990; 53():527-31. PubMed ID: 2239493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.